Veloxis Pharmaceuticals A/S announced that John Weinberg, M.D., currently chief commercial officer of Veloxis, has been promoted to chief operating officer. Dr. Weinberg, who is currently responsible for the commercial launch of Envarsus in the U.S., if approved by the Food and Drug Administration (FDA), will expand his role at the company to include additional operational responsibilities.